Asset Details
Do you wish to reserve the book?
Human milk immunomodulatory proteins are related to development of infant body composition during the first year of lactation
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Human milk immunomodulatory proteins are related to development of infant body composition during the first year of lactation
Do you wish to request the book?
Human milk immunomodulatory proteins are related to development of infant body composition during the first year of lactation
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Human milk immunomodulatory proteins are related to development of infant body composition during the first year of lactation
2021
Overview
Background
To investigate relationships between infant body composition (BC) and human milk (HM) immunomodulatory proteins (IMPs) during the first 12 months of lactation.
Methods
BC of breastfeeding dyads (
n
= 20) was measured with ultrasound skinfolds (infants) and bioimpedance spectroscopy (infants/mothers) at 2, 5, 9, and/or 12 months post partum. Breastfeeding frequency, 24-h milk intake, and IMP concentrations (lactoferrin, lysozyme, secretory immunoglobulin A (sIgA)) were measured, and calculated daily intakes (CDIs) were determined. We used linear regression/mixed-effects models and adjusted results for multiple comparisons.
Results
No associations were seen between maternal characteristics and IMP concentrations/CDIs or between IMP concentrations and infant BC. Lactoferrin CDI was negatively associated with infant fat-free mass index (
P
= 0.002); lysozyme CDI was positively associated with infant fat mass (
P
= 0.004) and fat mass index (
P
= 0.004) measured with ultrasound skinfolds.
Conclusion
In this small cohort of infants breastfed on demand during first year of life, we report differential associations of HM IMPs with infant BC, showing that in addition to their critical role in shaping infant immunity, lactoferrin, and lysozyme also influence development of infant BC, highlighting the importance of breastfeeding for 12 months and beyond.
Impact
HM IMPs (concentrations and, most importantly, daily intakes) time-dependently and differentially associate with development of infant lean mass and adiposity during first 12 months of lactation.
There is no information on how intakes and concentrations of these components affect development of infant BC.
HM contains IMPs—lactoferrin, lysozyme, and sIgA, which not only play a critical role in shaping infant’s immunity, but also influence infant growth and development of BC, highlighting the importance of breastfeeding for 12 months and beyond and warranting careful consideration of the dose effects of supplemented formula.
